Borrelia burgdorferi—associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a-Reference-Cited by-同舟云学术

Borrelia burgdorferi—associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a

Published:1997-02 Issue:2 Volume:36 Page:311-314
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Kütting Birgitta,Bonsmann Gisela,Metze Dieter,Luger Thomas A.,Cerroni Lorenzo

Publisher

Elsevier BV

Subject

Dermatology

Reference16 articles.

1. Acrodermatitis chronica atrophicans Herxheimer in Kombination mit kutanem Lymphom;Gräβner;Hautarzt,1974

2. Acrodermatitis chronica atrophicans and malignant lymphoma;Goos;Acta Derm Venereol (Stockh),1971

3. Kutanes B-Zell-Lymphom bei chronischer Borrelia-Burgdorferi-Infektion. Benicht über 2 Fälle und Literaturübersicht;Garbe;Hautarzt,1988

4. Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases;Garbe;J Am Acad Dermatol,1991

5. Inflammatory diseases that simulate lymphomas: Cutaneous pseudolymphomas;Kerl,1993

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of haematologic cancers among individuals tested for Borrelia burgdorferi antibodies, and Borrelia burgdorferi seropositive individuals: a nationwide population-based matched cohort study;Clinical Microbiology and Infection;2024-02

2. Pediatric Primary Cutaneous Marginal Zone Lymphoma Treated With Doxycycline;Cutis;2023-11

3. Management of Marginal Zone Lymphoma: A Canadian Perspective;Current Oncology;2023-02-01

4. Clinical relevance of molecular aspects in extranodal marginal zone lymphoma: a critical appraisal;Therapeutic Advances in Medical Oncology;2023-01

5. Bacterial infection-driven lymphomagenesis;Current Opinion in Oncology;2022-07-25